Network origin in Wayne A. Jefferson first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Lifebank Corp.
 Lifebank Corp. Medical/Nursing ServicesHealth Services Lifebank Corp. is a cryogenic facility company engages in the business of processing and cryopreserving umbilical cord blood stem cells for families. It offers clinically proven procedures available for the cryogenic storage of umbilical cord blood stem cells. It uses umbilical cord stem cells for the treatment of diseases, such as leukemia, metabolic disorders, immune disorders, bone marrow failure, genetic disorders, and many others. Lifebank markets its services by using various avenues including distributing brochures to doctors' offices, clinics and hospitals, delivering lectures to groups of doctors and other healthcare providers, speaking at prenatal classes, and maintaining contact with the media to encourage informed articles about umbilical cord blood stem cells. The company was founded on Feb 21, 1996 and is headquartered in Burnaby, Canada.
6
| Extinct | Medical/Nursing Services | 6 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Wayne A. Jefferson via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| CECO ENVIRONMENTAL CORP. | Industrial Machinery | Director/Board Member | |
| BIG TREE GROUP, INC. | Services to the Health Industry | Director of Finance/CFO | |
| AETERNA ZENTARIS INC. | Pharmaceuticals: Major | Director/Board Member | |
| PINETREE CAPITAL LTD. | Financial Conglomerates | Director/Board Member | |
| SIERRA WIRELESS, INC. | Electronic Production Equipment | Director of Finance/CFO | |
| WESTBOND ENTERPRISES CORPORATION | Household/Personal Care | Director of Finance/CFO Director/Board Member | |
| INMED PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| HANFENG EVERGREEN INC. | Chemicals: Agricultural | Director/Board Member | |
JMP Group, Inc.
 JMP Group, Inc. Investment Banks/BrokersFinance JMP Group Inc. is a full-service investment banking and asset management firm, together with its subsidiaries it provides investment banking, sales and trading, and equity research services to corporate and institutional clients, and alternative asset management products and services to institutional investors and high net-worth individuals. The company operates its business through five segments: Broker-Dealer, Asset Management, Corporate Credit, Investment Income, Eliminations and Corporate Costs. The Broker-Dealer segment includes a broad range of services, such as underwriting and acting as a placement agent for public and private capital markets raising transactions and financial advisory services in M&A, restructuring and other strategic transactions. The Broker-Dealer segment also includes institutional brokerage services and equity research services to institutional investor clients. The Asset Management segment includes the management of a broad range of pooled investment vehicles, including the company's hedge funds, hedge funds of funds. The Corporate Credit segment includes the management of collateralized loan obligations and small business loans. The Investment Income segment includes income from the company's principal investments in public and private securities, as well as any other net interest and income from investing activities. The Corporate Costs segment includes expenses related to JMP Group Inc., the holding company, and JMP Group LLC, and is mainly comprised of corporate overhead expenses and interest expense related to the company's credit facility with City National Bank. JMP Group was founded by Joseph A. Jolson and Carter D. Mack in 1999 and is headquartered in San Francisco, CA. | Investment Banks/Brokers | President | |
| ARBUTUS BIOPHARMA CORPORATION | Pharmaceuticals: Major | Director of Finance/CFO | |
| OREZONE GOLD CORPORATION | Precious Metals | Director of Finance/CFO | |
| GLOBAL GAMING TECHNOLOGIES CORP. | Financial Conglomerates | Director of Finance/CFO | |
| NORTHERN GRAPHITE CORPORATION | Other Metals/Minerals | Chief Administrative Officer | |
DuMoulin Black LLP
 DuMoulin Black LLP Miscellaneous Commercial ServicesCommercial Services DuMoulin Black LLP operates as a corporate finance and securities law firm. It practices in the areas of mergers and acquisitions, proxy contests, corporate governance and corporate law. The company was founded in 1966 and is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Violy, Byorum & Partners LLC
 Violy, Byorum & Partners LLC Investment ManagersFinance Violy, Byorum & Partners LLC provides strategic advisory and investment banking services. The company was founded by Violy McCausland-Seve and is headquartered in New York, NY. | Investment Managers | Corporate Officer/Principal | |
| McGill University | College/University | Undergraduate Degree | |
| Brigham Young University | College/University | Undergraduate Degree | |
| University of British Columbia | College/University | Undergraduate Degree Undergraduate Degree | |
| Simon Fraser University | College/University | Undergraduate Degree | |
| London School of Economics & Political Science | College/University | Graduate Degree | |
McCullough O'Connor Irwin LLP
 McCullough O'Connor Irwin LLP Miscellaneous Commercial ServicesCommercial Services McCullough O'Connor Irwin LLP is a Canadian law firm with 400 lawyers and business advisors across multiple locations in Canada and internationally. The private company is based in Vancouver, Canada. The firm specializes in complex cross-border and international transactions, making it well-suited to advise foreign businesses and investors with Canadian ventures, and connect Canadian businesses and investors with opportunities around the world. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| API TECHNOLOGIES CORP | Semiconductors | Director/Board Member | |
| LIGNOL ENERGY CORPORATION | Chemicals: Specialty | Director of Finance/CFO | |
| Mount Sinai Hospital Foundation of Toronto | Director/Board Member | ||
| Crescent School Foundation | Director/Board Member | ||
viDA Therapeutics, Inc.
 viDA Therapeutics, Inc. BiotechnologyHealth Technology viDA Therapeutics, Inc. operates as a biotechnology company. It offers discovery, development and commercialization of novel and targeted therapeutics for the treatment of inflammatory and age related diseases. The firm's discovery platform is based on novel research regarding a distinctly different and recently identified, extracellular role for granzymes in the destruction and inflammation of tissues. The company was founded by Alistair Duncan Jr. and David Granville in 2008 and is headquartered in Vancouver, Canada. | Biotechnology | Director of Finance/CFO | |
| KAB DISTRIBUTION INC. | Internet Software/Services | Director of Finance/CFO | |
| JMP Fam Holdings, Inc. | President | ||
The Chartered Professional Accountants of British Columbia
 The Chartered Professional Accountants of British Columbia Miscellaneous Commercial ServicesCommercial Services The Chartered Professional Accountants of British Columbia is an association of accountants based in Vancouver, Canada. and has subsidiaries in Australia. The Canadian company operates as an association of accountants. The CEO of the private company is Lori Mathison. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| ILLUMIN HOLDINGS INC. | Internet Software/Services | Director of Finance/CFO | |
| ARHT MEDIA INC. | Information Technology Services | Director/Board Member | |
| ENVIROMETAL TECHNOLOGIES INC. | Chemicals: Specialty | Director of Finance/CFO | |
I-5 Holdings Ltd.
 I-5 Holdings Ltd. Financial ConglomeratesFinance I-5 Holdings Ltd. operates as an investment holding company which focuses on cannabis products and investment services to the public. The company is headquartered in Vancouver, Canada. | Financial Conglomerates | Director/Board Member | |
| EVE & CO INCORPORATED | Pharmaceuticals: Other | Director/Board Member | |
| Proactive Immune Sciences Corp. | Director of Finance/CFO | ||
| Samacha Capital, Inc. | President | ||
ImStar Therapeutics, Inc.
 ImStar Therapeutics, Inc. BiotechnologyHealth Technology ImStar Therapeutics, Inc. develops therapies for ALS and neurodegenerative disease. The firm's lead drug candidate is IMS-088, a small-molecule compound currently in preclinical development. It is studying compounds directed at a proprietary new therapeutic target for ALS called TANA. The company was founded by Daniel J. Wattier and Jean-Pierre Julien in 2012 and is headquartered in Vancouver, Canada. | Biotechnology | Director of Finance/CFO | |
| The Sterling Hall School | College/University | Director/Board Member |
Statistics
International
| Canada | 37 |
| United States | 10 |
| China | 2 |
| United Kingdom | 2 |
Sectoral
| Finance | 10 |
| Health Technology | 9 |
| Consumer Services | 8 |
| Technology Services | 5 |
| Non-Energy Minerals | 4 |
Operational
| Director of Finance/CFO | 22 |
| Director/Board Member | 21 |
| Corporate Secretary | 10 |
| Corporate Officer/Principal | 9 |
| Independent Dir/Board Member | 6 |
Most connected contacts
| Insiders | |
|---|---|
| Jonathan Pollack | 23 |
| Jeffrey Charpentier | 13 |
| Nathalie Pilon | 6 |
| J. Seppala | 5 |
| Alan C. Herrington | 5 |
| Owen Ross Granger | 3 |
- Stock Market
- Insiders
- Wayne A. Jefferson
- Company connections
